TIMP‑3 suppresses the proliferation and migration of SMCs from the aortic neck of atherosclerotic AAA in rabbits, via decreased MMP‑2 and MMP‑9 activity, and reduced TNF‑α expression

Zhai,Huan; Qi,Xun; Li,Zixuan; Zhang,Wei; Li,Chenguang; Ji,Lu; Xu,Ke; Zhong,Hongshan

doi:10.3892/mmr.2018.9224

TIMP‑3 suppresses the proliferation and migration of SMCs from the aortic neck of atherosclerotic AAA in rabbits, via decreased MMP‑2 and MMP‑9 activity, and reduced TNF‑α expression

Authors:
- Huan Zhai
- Xun Qi
- Zixuan Li
- Wei Zhang
- Chenguang Li
- Lu Ji
- Ke Xu
- Hongshan Zhong
View Affiliations

Affiliations: Department of Interventional Radiology, First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China, Key Laboratory of Diagnostic Imaging and Interventional Radiology of Liaoning Province, First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: June 26, 2018 https://doi.org/10.3892/mmr.2018.9224
Pages: 2061-2067
Copyright: © Zhai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated the role of tissue inhibitor of matrix metalloproteinase‑3 (TIMP‑3) in regulating the proliferation, migration, apoptosis and activity of matrix metalloproteinase (MMP)‑2 and ‑9, during the development of an atherosclerotic abdominal artery aneurysm (AAA). Experiments were conducted using rabbit AAA neck (NA) smooth muscle cells (SMCs), to investigate the potential for TIMP‑3 to be used as a novel stent coating in preventing aortic dilation adjacent to the AAA. The atherosclerotic AAA model was induced in New Zealand white rabbits via a 6‑week high‑cholesterol diet, followed by incubation of the targeted aortic region with elastase. SMCs were isolated from the aorta adjacent to the aneurysm 30 days after AAA model induction, and stimulated with 3, 10, 30 or 100 ng/ml TIMP‑3. Cell proliferation was investigated using Cell Counting Kit‑8 reagent, migration was examined using a Boyden chamber assay and apoptotic rate was analyzed using the Annexin V‑fluorescein isothiocyanate Apoptosis Detection kit. Gelatin zymography and ELISA were used to measure the activity of MMP‑2 and MMP‑9, and the expression of tumor necrosis factor‑α (TNF‑α), respectively. Analysis of cell proliferation indicated that 10, 30 and 100 ng/ml TIMP‑3 reduced cell viability. Cell migration was decreased by 10, 30 and 100 ng/ml TIMP‑3. MMP‑2 activity was inhibited by 10, 30 and 100 ng/ml TIMP‑3, and MMP‑9 activity was suppressed by 30 and 100 ng/ml TIMP‑3. The protein levels of secreted TNF‑α were reduced by 10, 30 and 100 ng/ml TIMP‑3. The present study demonstrated the ability of 30 and 100 ng/ml TIMP‑3 to attenuate migration and proliferation, and to inhibit the activity of MMP‑2, MMP‑9 and TNF‑α secretion of NA SMCs. In conclusion, TIMP‑3 may be considered a potential therapeutic drug for use in a novel drug‑eluting stent, to attenuate the progressive dilation of the aortic NA.

View Figures

View References

1	Roggerio A, Sambiase NV, Palomino SA, de Castro MA, da Silva ES, Stolf NG and de Lourdes Higuchi M: Correlation of bacterial coinfection versus matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 expression in aortic aneurysm and atherosclerosis. Ann Vasc Surg. 27:964–971. 2013. View Article : Google Scholar : PubMed/NCBI
2	Lovegrove RE, Javid M, Magee TR and Gall RB: A meta-analysis of 21,178 patients undergoing open or endovascular repair of abdominal aortic aneurysm. Br J Surg. 95:677–684. 2008. View Article : Google Scholar : PubMed/NCBI
3	Brewster DC, Jones JE, Chung TK, Lamuraglia GM, Kwolek CJ, Watkins MT, Hodgman TM and Cambria RP: Long-term outcomes after endovascular abdominal aortic aneurysm repair: The first decade. Ann Surg. 244:426–438. 2006.PubMed/NCBI
4	van Herwaarden JA, van de Pavoordt ED, Waasdorp EJ, Vos Albert J, Overtoom TT, Kelder JC, Moll FL and de Vries JP: Long-term single-center results with AneuRx endografts for endovascular abdominal aortic aneurysm repair. J Endovasc Ther. 14:307–317. 2007. View Article : Google Scholar : PubMed/NCBI
5	Peterson BG, Matsumura JS, Brewster DC and Makaroun MS: Excluder Bifurcated Endoprosthesis Invistigators: Five-year report of a multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysms. J Vasc Surg. 45:885–890. 2007. View Article : Google Scholar : PubMed/NCBI
6	White RA, Donayre CE, Walot I, Kopchok GE, Wilson EP and deVirgilio C: Regression of an abdominal aortic aneurysm after endograft exclusion. J Vasc Surg. 26:133–137. 1997. View Article : Google Scholar : PubMed/NCBI
7	Rodway AD, Powell JT, Brown LC and Greenhalgh RM: Do abdominal aortic aneurysm necks increase in size faster after endovascular than open repair? Eur J Vasc Endovasc Surg. 35:685–693. 2008. View Article : Google Scholar : PubMed/NCBI
8	Diehm N, Dick F, Katzen BT, Schmidli J, Kalka C and Baumgartner I: Aortic neck dilatation after endovascular abdominal aortic aneurysm repair: A word of caution. J Vasc Surg. 47:886–892. 2008. View Article : Google Scholar : PubMed/NCBI
9	Badran MF, Gould DA, Raza I, McWilliams RG, Brown O, Harris PL, Gilling-Smith GL, Brennan J, White D, Meakin S and Rowlands PC: Aneurysm neck diameter after endovascular repair of abdominal aortic aneurysms. J Vasc Interv Radiol. 13:887–892. 2002. View Article : Google Scholar : PubMed/NCBI
10	Conners MS III, Sternbergh WC III, Carter G, Tonnessen BH, Yoselevitz M and Money SR: Endograft migration one to four years after endovascular abdominal aortic aneurysm repair with the AneuRx device: A cautionary note. J Vasc Surg. 36:476–484. 2002. View Article : Google Scholar : PubMed/NCBI
11	Tanaka A, Hasegawa T, Morimoto K, Bao W, Yu J, Okita Y, Tabata Y and Okada K: Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm model. J Vasc Surg. 60:749–758. 2014. View Article : Google Scholar : PubMed/NCBI
12	Tsarouhas K, Soufla G, Apostolakis S, Zaravinos A, Panagiotou M, Khoury M, Hassoulas JA, Tsatsakis AM and Spandidos DA: Transcriptional regulation of TIMPs in ascending aorta aneurysms. Thromb Res. 126:399–405. 2010. View Article : Google Scholar : PubMed/NCBI
13	Raffetto JD and Khalil RA: Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 75:346–359. 2008. View Article : Google Scholar : PubMed/NCBI
14	Scott RA, Paderi JE, Sturek M and Panitch A: Decorin mimic inhibits vascular smooth muscle proliferation and migration. PLoS One. 8:e824562013. View Article : Google Scholar : PubMed/NCBI
15	Saratzis A, Abbas AA, Kiskinis D, Melas N, Saratzis N and Kitas GD: Abdominal aortic aneurysm: A review of the genetic basis. Angiology. 62:18–32. 2011. View Article : Google Scholar : PubMed/NCBI
16	Doran AC, Meller N and McNamara CA: Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 28:812–819. 2008. View Article : Google Scholar : PubMed/NCBI
17	Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P and Blobel CP: Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol. 164:769–779. 2004. View Article : Google Scholar : PubMed/NCBI
18	Leco KJ, Khokha R, Pavloff N, Hawkes SP and Edwards DR: Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem. 269:9352–9360. 1994.PubMed/NCBI
19	Yu WH, Yu S, Meng Q, Brew K and Woessner JF Jr: TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem. 275:31226–31232. 2000. View Article : Google Scholar : PubMed/NCBI
20	Cardellini M, Menghini R, Martelli E, Casagrande V, Marino A, Rizza S, Porzio O, Mauriello A, Solini A, Ippoliti A, et al: TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes. 58:2396–2401. 2009. View Article : Google Scholar : PubMed/NCBI
21	Knox JB, Sukhova GK, Whittemore AD and Libby P: Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation. 95:205–212. 1997. View Article : Google Scholar : PubMed/NCBI
22	Ikonomidis JS, Jones JA, Barbour JR, Stroud RE, Clark LL, Kaplan BS, Zeeshan A, Bavaria JE, Gorman JH III, Spinale FG and Gorman RC: Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. J Thorac Cardiovasc Surg. 133:1028–1036. 2007. View Article : Google Scholar : PubMed/NCBI
23	Mahller YY, Vaikunth SS, Ripberger MC, Baird WH, Saeki Y, Cancelas JA, Crombleholme TM and Cripe TP: Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors. Cancer Res. 68:1170–1179. 2008. View Article : Google Scholar : PubMed/NCBI
24	Bi Y, Zhong H, Xu K, Ni Y, Qi X, Zhang Z and Li W: Performance of a modified rabbit model of abdominal aortic aneurysm induced by topical application of porcine elastase: 5-month follow-up study. Eur J Vasc Endovasc Surg. 45:145–152. 2013. View Article : Google Scholar : PubMed/NCBI
25	Johnsen SH, Forsdahl SH, Singh K and Jacobsen BK: Atherosclerosis in abdominal aortic aneurysms: A causal event or a process running in parallel? The Tromso study. Arterioscler Thromb Vasc Biol. 30:1263–1268. 2010. View Article : Google Scholar : PubMed/NCBI
26	Golledge J, Clancy P, Moran C, Biros E, Rush C, Walker P and Norman P: The novel association of the chemokine CCL22 with abdominal aortic aneurysm. Am J Pathol. 176:2098–2106. 2010. View Article : Google Scholar : PubMed/NCBI
27	Biros E, Moran CS, Rush CM, Gäbel G, Schreurs C, Lindeman JH, Walker PJ, Nataatmadja M, West M, Holdt LM, et al: Differential gene expression in the proximal neck of human abdominal aortic aneurysm. Atherosclerosis. 233:211–218. 2014. View Article : Google Scholar : PubMed/NCBI
28	Karki R, Jeon ER and Kim DW: Nelumbo nucifera leaf extract inhibits neointimal hyperplasia through modulation of smooth muscle cell proliferation and migration. Nutrition. 29:268–275. 2013. View Article : Google Scholar : PubMed/NCBI
29	Saracini C, Bolli P, Sticchi E, Pratesi G, Pulli R, Sofi F, Pratesi C, Gensini GF, Abbate R and Giusti B: Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm. J Vasc Surg. 55:171–179.e2. 2012. View Article : Google Scholar : PubMed/NCBI
30	Riches K, Angelini TG, Mudhar GS, Kaye J, Clark E, Bailey MA, Sohrabi S, Korossis S, Walker PG, Scott DJ and Porter KE: Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysm. J Transl Med. 11:2082013. View Article : Google Scholar : PubMed/NCBI
31	Kang YH, Yang IJ and Shin HM: Herbal formula HMC05 prevents human aortic smooth muscle cell migration and proliferation by inhibiting the ERK1/2 MAPK signaling cascade. J Nat Med. 66:177–184. 2012. View Article : Google Scholar : PubMed/NCBI
32	Goetze S, Xi XP, Kawano Y, Kawano H, Fleck E, Hsueh WA and Law RE: TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension. 33:183–189. 1999. View Article : Google Scholar : PubMed/NCBI
33	Hingorani A, Ascher E, Scheinman M, Yorkovich W, DePippo P, Ladoulis CT and Salles-Cunha S: The effect of tumor necrosis factor binding protein and interleukin-1 receptor antagonist on the development of abdominal aortic aneurysms in a rat model. J Vasc Surg. 28:522–526. 1998. View Article : Google Scholar : PubMed/NCBI
34	Hultin MB, Shapiro SS, Bowman HS, Gill FM, Andrews AT, Martinez J, Eyster EM and Sherwood WC: Immunosuppressive therapy of Factor VIII inhibitors. Blood. 48:95–108. 1976.PubMed/NCBI
35	Zhong H, Matsui O, Xu K, Ogi T, Sanada J, Okamoto Y, Tabata Y and Takuwa Y: Gene transduction into aortic wall using plasmid-loaded cationized gelatin hydrogel-coated polyester stent graft. J Vasc Surg. 50:1433–1443. 2009. View Article : Google Scholar : PubMed/NCBI